Models for Understanding Resistance to Chemotherapy in Liver Cancer

The lack of response to pharmacological treatment constitutes a substantial limitation in the handling of patients with primary liver cancers (PLCs). The existence of active mechanisms of chemoresistance (MOCs) in hepatocellular carcinoma, cholangiocarcinoma, and hepatoblastoma hampers the usefulnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin, Jose J. G., Herraez, Elisa, Lozano, Elisa, Macias, Rocio I. R., Briz, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896032/
https://www.ncbi.nlm.nih.gov/pubmed/31671735
http://dx.doi.org/10.3390/cancers11111677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896032/
https://www.ncbi.nlm.nih.gov/pubmed/31671735
http://dx.doi.org/10.3390/cancers11111677

Ejemplares similares